×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear
Simply Wall Street
Shareholders appeared unconcerned with Astellas Pharma Inc.'s ( TSE:4503 ) lackluster earnings report last week. We...
16 hours ago
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel ...
PR Newswire
PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc. (NASDAQ: PSTX,...
2 days ago
Change in Definition of Core Basis in Financial Results News
Astellas Pharma
Astellas has been applying International Financial Reporting Standards to consolidated financial statements since FY2013, which ended March...
1 week ago
Astellas Inks Second CAR-T Agreement with Poseida to Develop ‘Convertible’ Cancer Therapies
BioSpace
Astellas Pharma and Poseida Therapeutics have entered into a second CAR-T contract to develop novel and flexible allogeneic cell therapies...
1 day ago
Astellas hops into Poseida's car for $50M cell therapy collab
Fierce Biotech
Astellas is in the market for a new CAR, and Poseida Therapeutics has a shiny convertible just the right size. The companies have signed an...
1 day ago
Astellas Announces Strategic Collaboration with Mass General Brigham
Mass General Brigham
Astellas Pharma Inc. announces it has entered into a strategic collaboration with Mass General Brigham.
3 months ago
Commitment to healthcare for local communities
Astellas Pharma
Based on our Raison D'être to “Contribute toward improving the health of people around the world through the provision of innovative and reliable...
1 week ago
Astellas and Poseida enter second research collaboration
The Pharma Letter
San Diego, USA-based clinical-stage cell and gene therapy company Poseida Therapeutics (Nasdaq: PSTX) saw its shares close up more than 20%...
1 day ago
Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Simply Wall Street
As you might know, Astellas Pharma Inc. ( TSE:4503 ) recently reported its annual numbers. It was not a great result...
4 days ago
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for ...
PR Newswire
PRNewswire/ -- Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK, President and CEO; Christophe Weber, "Takeda"), Astellas Pharma...
1 week ago